X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs PFIZER - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS PFIZER NOVARTIS/
PFIZER
 
P/E (TTM) x 261.0 30.0 870.8% View Chart
P/BV x 22.2 5.1 436.4% View Chart
Dividend Yield % 1.6 0.6 258.0%  

Financials

 NOVARTIS   PFIZER
EQUITY SHARE DATA
    NOVARTIS
Mar-17
PFIZER
Mar-16
NOVARTIS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs8552,724 31.4%   
Low Rs6661,611 41.3%   
Sales per share (Unadj.) Rs219.0440.9 49.7%  
Earnings per share (Unadj.) Rs19.148.7 39.2%  
Cash flow per share (Unadj.) Rs20.375.8 26.8%  
Dividends per share (Unadj.) Rs10.0015.00 66.7%  
Dividend yield (eoy) %1.30.7 190.1%  
Book value per share (Unadj.) Rs307.0462.9 66.3%  
Shares outstanding (eoy) m29.9645.75 65.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.54.9 70.6%   
Avg P/E ratio x39.844.5 89.4%  
P/CF ratio (eoy) x37.528.6 130.9%  
Price / Book Value ratio x2.54.7 52.9%  
Dividend payout %52.430.8 170.0%   
Avg Mkt Cap Rs m22,77999,163 23.0%   
No. of employees `0000.72.9 23.3%   
Total wages/salary Rs m1,3932,758 50.5%   
Avg. sales/employee Rs Th9,736.26,981.7 139.5%   
Avg. wages/employee Rs Th2,066.8954.5 216.5%   
Avg. net profit/employee Rs Th849.0771.1 110.1%   
INCOME DATA
Net Sales Rs m6,56220,170 32.5%  
Other income Rs m702857 81.8%   
Total revenues Rs m7,26421,028 34.5%   
Gross profit Rs m2594,310 6.0%  
Depreciation Rs m361,239 2.9%   
Interest Rs m75 138.5%   
Profit before tax Rs m9173,923 23.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m3451,794 19.2%   
Profit after tax Rs m5722,228 25.7%  
Gross profit margin %3.921.4 18.5%  
Effective tax rate %37.645.7 82.3%   
Net profit margin %8.711.0 78.9%  
BALANCE SHEET DATA
Current assets Rs m9,73116,299 59.7%   
Current liabilities Rs m1,8307,594 24.1%   
Net working cap to sales %120.443.2 279.0%  
Current ratio x5.32.1 247.7%  
Inventory Days Days4965 74.6%  
Debtors Days Days2526 97.7%  
Net fixed assets Rs m578,622 0.7%   
Share capital Rs m141458 30.8%   
"Free" reserves Rs m9,05620,722 43.7%   
Net worth Rs m9,19621,180 43.4%   
Long term debt Rs m025 0.0%   
Total assets Rs m11,49929,137 39.5%  
Interest coverage x128.4755.5 17.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.7 82.4%   
Return on assets %5.07.7 65.7%  
Return on equity %6.210.5 59.2%  
Return on capital %10.119.0 52.9%  
Exports to sales %00.1 0.0%   
Imports to sales %017.5 0.0%   
Exports (fob) Rs mNA12 0.0%   
Imports (cif) Rs mNA3,526 0.0%   
Fx inflow Rs m12952 249.6%   
Fx outflow Rs m1,734140 1,238.7%   
Net fx Rs m-1,605-88 1,817.0%   
CASH FLOW
From Operations Rs m-3803,436 -11.0%  
From Investments Rs m4,208-6,991 -60.2%  
From Financial Activity Rs m-3,318-619 536.2%  
Net Cashflow Rs m510-4,174 -12.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.4%  
Indian inst/Mut Fund % 2.0 7.5 26.7%  
FIIs % 1.6 4.9 32.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 23.7 90.7%  
Shareholders   41,647 85,207 48.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ORCHID PHARMA LTD  WYETH LTD  ASTRAZENECA PHARMA  SUVEN LIFE  CIPLA  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 22, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS